Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 55

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 55
---
GenIvf’s
solutions decline or grow more slowly than it expects, or if the number of clients that contract with it for its solutions declines or
fails to increase as it expects, its financial results could be harmed. As the markets in which NewGenIvf participate mature, fertility
solutions and services evolve and competitors begin to enter into the market and introduce differentiated solutions or services that are
perceived to compete with its solutions, particularly if such competing solutions are adopted by its competitors, its ability to sell
its solutions could be impaired. As a result of these and other factors, NewGenIvf may be unable to attract new clients, which would have
an adverse effect on its business, financial condition and results of operations.

NewGenIvf’s business depends on its ability to maintain its existing client demographics. Any failure to do so would harm its business, financial condition and results of operations.

As part of its growth
strategy, NewGenIvf is focused on maintaining its services within its existing client demographics. NewGenIvf mainly competes with
mid-level private clinics and hospitals, which have improved and developed their services and equipment over the years. In
addition to private clinics and hospitals already existing, foreign medical companies may also enter the markets where NewGenIvf
operates. Such foreign medical companies may be well-placed to compete with NewGenIvf due to their larger network size, reputation
as global players and access to more advanced technology and financial resources. The expansion of existing competitors in the
industry may erode NewGenIvf’s existing market share or decrease its traditional client pool. There can be no assurance that
NewGenIvf will be able to compete effectively and therefore its future business growth may suffer.

<div align='center'>31</div>

A significant reduction in the utilization of NewGenIvf’s solutions could have an adverse effect on its business, financial condition and results of operations.

A significant reduction in
the number of clients using NewGenIvf’s solutions could adversely affect its business, financial condition and results of operations.
Factors that could contribute to a reduction in the use of its solutions include: general economic downturn that results in adverse financial
conditions; regulatory changes; failure to adapt and respond effectively to changing medical landscape, changing regulations, changing
client needs, requirements or preferences; negative publicity, through social media or otherwise and news coverage.

If NewGenIvf fails to offer high-quality support, its reputation could suffer.

NewGenIvf relies on